Clinsight

Uppsala, Sweden

Clinsight is a spin out from Karolinska Institutet which are developing and commercializing best in class artificial intelligence systems for diagnosis, Gleason grading and prognosis of prostate cancer. Our AI based systems have the highest level of validation, generalizable across different slidescanners seamlessly integrated into existing digital pathology workflows. Our mission is to improve reproducibility, accuracy and standardization of diagnosis and Gleason grading as well as predicting relapse of prostate cancer.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Clinsight on @MedStartr Today #ProstateCancer #CancerDiagnosis #AIML #Diagnostics #Pathology #MedMo #MedStartrVentures

https://www.medstartr.ai/s/cGgQjs81x7Y

Get Involved in Clinsight

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2022
Website: www.clinsight.net/

Disease Areas

Prostate Cancer Cancer Diagnosis

Technologies

AI/Machine LearningAI-powered SoftwareAI in DiagnosticsDigital Pathology

🌐Website

What do you think of Clinsight?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.